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Role of angiotensin in kidney and urinary tract congenital
anomalies in the mouse and the human. The role of angiotensin
in fluid and electrolyte and blood pressure homeostasis is well
known. Recent developments indicate that angiotensin has a
profound role not only in the developing urinary tract but also in
the response of the urinary tract to specific noxious stimuli.
Furthermore, the role of angiotensin II and its receptor has been
understood quite poorly with respect to the developing renal unit.
Knockout mice for the ATR2 gene show a significant incidence of
congenital urinary tract anomalies. The congenital anomalies of
the kidney and urinary tract (CAKUT) seen in these mice are very
similar to the anomalies observed in humans. This has been
supported further by the finding of an abnormality in the genetic
sequence in patients with CAKUT. This article reviews experi-
mental laboratory data as well as the potential implications for
humans.
Angiotensin (Ang) is best known for its role in the
regulation of blood pressure. Ang achieves its homeostatic
function highly efficiently, that is, by concurrently utilizing
several biological measures, such as, regulation of aldoste-
rone synthesis, salt appetite, and peripheral vascular resis-
tance. As in many other homeostatic mechanisms, the
generation of Ang, in turn, is regulated in a remarkably
precise manner. Thus, when renal perfusion pressure falls,
such as, as a result of dehydration or mechanical hindrance
to renal arterial blood flow, the release of renin, and hence
Ang, surges (Fig. 1). Ang continues to increase, raising
systemic blood pressure so that renal perfusion pressure
returns to a near baseline level (Fig. 1). Thanks to the
pioneering work of Dr. Thurau, his associates, and other
investigators, we now know that the macula densa and the
juxtaglomerular apparatus are the key players in this feed-
back regulation of renin-angiotensin release [1–3]. Overall,
the kidney is designed to preserve its own hydrodynamic
environment, and Ang is a biological tool to perform this
function.
Renin-angiotensin release also surges when urine out-
flow is mechanically hindered (Fig. 1) [4]. This phenome-
non of ureteral pressure-sensitive activation of renin-angio-
tensin has been heretofore viewed as an error of nature and
often even as harmful to the kidney [5]. The challenge to
this traditional view came when we examined several
strains of mutant mice that are completely devoid of either
Ang type 1 (AT1) receptor gene (Agtr1) or Ang type 2
(AT2) receptor gene (Agtr2) as a result of genetic manip-
ulation of these genes [6, 7]. As discussed in more detail
later here, these strains of mice display varying degrees of
urinary tract obstruction, either structural or functional in
nature. Some obstructions develop during early kidney
ontogenesis in utero and others during late ontogenesis ex
utero.
One may recall that, throughout normal ontogenesis, the
kidney is constantly at risk for obstruction of urine outflow.
Thus, in utero [;embryonic (E) day 14 in mice; ;day E40
in humans], the ureter is transiently obliterated [8]. This
transient obliteration is believed to protect the kidney from
the high pressure from the cloaca when urine is not yet
formed. During this period, dense layers of undifferenti-
ated mesenchymal cells surround the ureter. Subsequent
expansive growth that the ureter must achieve, therefore,
occurs in concert with the timely disappearance of the
surrounding mesenchymal cells. The study in mouse em-
bryos with Agtr2 null mutation [6] indicated that Ang,
through the AT2 receptor, promotes disappearance of
these mesenchymal cells and that inactivation of this recep-
tor results in congenital obstructive nephropathy. Once
animals are born, the kidney assumes primary importance
for preservation of body fluid homeostasis, and urinary
output increases dramatically. The large volume of urine
predisposes the kidney to obstructive nephropathy due to
the high resistance offered to the urine by the downstream
ureter. Normally, a special device develops within the
urinary tract in a timely fashion that enables the kidney to
collect a bulk of urine and then to expel it downward
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periodically without imposing positive pressure on the renal
parenchyma. This special device is the renal pelvis, which
comprises smooth muscle cells with a pacemaker function
[9]. The pacemaker cells initiate the chain reaction of
peristalsis downward. Remarkably, the muscle cells of the
pelvis are distributed not only outside the perimeter of the
renal parenchyma, but also extensively inside, so that the
co-ordinated contraction of the pelvis prevents transmis-
sion of positive pressure to the renal parenchyma by
transiently shutting off communication between the calyx
and the pelvis. As described later here, in a recent series of
studies on Agtr1 null mutant mice [7], Ang, through the
AT1 receptor, promotes development of the pacemaker
cells within the pelvis shortly after birth so that inactivation
of this receptor leads to absence of development of the
pelvis, hence to obstructive nephropathy.
Collectively, the studies on Agtr1 or Agtr2 null mutant
mice indicate that the animals that lack intact Ang receptor
systems suffer from urinary tract obstruction. Given that
urinary tract obstruction per se is a potent stimulus for Ang
generation, the observed function of Ang to allow the
kidney to escape from obstructive nephropathy is function-
ally significant and biologically important. This mechanism
has all of the necessary components of an effective feed-
back mechanism; that is, the mechanism has a sensor to a
stimulatory signal (that is, ureteral pressure), and the
activated mediator (that is, Ang) is geared toward damp-
ening the signal toward baseline level. Yet to be deter-
mined is whether this feedback system, seemingly impor-
tant in avoiding obstructive nephropathy in growing
animals, also functions in mature animals.
PHENOTYPE OF AT2 RECEPTOR NULL MUTANTS
The embryonic development of the kidney and urinary
tract takes place in concert with the disappearance of
undifferentiated mesenchymal cells, which densely sur-
round the Wolffian duct initially, then, the ureter and
nephronogenic centers within the metanephros [10]. AT2
receptor transcriptional activity is transiently up-regulated
in utero in close association with the disappearance of these
mesenchymal cells. Mice carrying a targeted null mutation
of Agtr2 sometimes display congenital anomalies of the
kidney and urinary tract (CAKUT) [6]. CAKUT are male-
preponderant and predominantly unilateral and include the
following defects, either alone or in combination: hypoplas-
tic kidney, multicystic dysplastic kidney (MCDK), uretero-
pelvic junction (UPJ) stenosis/atresia, and megaureter.
Mild reflux of urine from the bladder to the ureter afflicts
more null mutants without gross anatomical anomalies. In
addition to all of the previously mentioned features, other
characteristic features, including histological patterns, the
onset of anomalies in utero, and absence of other somatic
defects, also closely mimic those of human CAKUT.
To determine if variants of the Agtr2 gene underlie the
manifestation of CAKUT in humans, we analyzed the AT2
genes from a cohort of United States Caucasians with UPJ
obstruction with or without or MCDK and controls [11].
Using genomic DNA from five patients and two controls as
templates, polymerase chain reaction amplicons containing
exons 1 to 3 and introns 1 and 2 of the Agtr2 gene were
obtained. These amplicons were then screened for se-
quence alterations by dideoxy fingerprinting followed by
DNA sequencing. We identified only one polymorphic
locus in the ;2.5-kb length examined, which is an A to G
transition within intron 1. This transition occurred in 74%
of the 23 affected males, but only 19% of the 16 controls (x2
5 11.5, P , 0.001). Thus, our studies identified a nucleo-
tide transition in the human AT2 gene that is associated
with UPJ obstruction and/or MCDK. These findings sug-
gest that the AT2 gene variance in the polymorphic locus
identified in the study or a nearby mutation may also
contribute to other forms of CAKUT in humans.
To explore the mechanism through which defective AT2
receptor may cause CAKUT, we studied the effect of Ang
(1026 M) on the ureter dissected from E14.5 mouse em-
bryos and cultured in vitro [12]. Under the culture condi-
tions that we established, the ureter grows and differenti-
ates and is characterized by a simple epithelial tubelike
structure surrounded by dense undifferentiated mesenchy-
mal cell layers that express AT2 mRNAs. Ureters were
then nick labeled to quantify the activity of apoptosis.
Fig. 1. Response of angiotensin (Ang) II formation to renal arterial or
ureteral obstruction.
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Studies were then conducted on ureters from both wild-
type and Agtr2 null mutant embryos. Results showed that
treatment with Ang II, but not vehicle alone, increases
nick-positive cells among undifferentiated mesenchymal
cells in the wild-type ureter. In contrast, Ang II treatment
did not increase nick positivity in ureters from Agtr2 null
mutant embryos. Additionally, microscopic studies on Agtr2
null mutant embryos further identified delayed apoptosis of
undifferentiated mesenchymal cells in utero as an interme-
diary phenotype preceding CAKUT in the mutant. Collec-
tively, these results indicate first that embryonic activation
of the AT2 receptor has a significant role in the normal
growth and development of the kidney and ureter. Second,
the diverse anatomical patterns of CAKUT share a com-
mon ontogenic mechanism of delayed apoptosis of UMCs,
which hinders key events of kidney and urinary tract
development from the first ureteral budding to their sub-
sequent expansive physical growth.
PHENOTYPE OF AT1 RECEPTOR NULL MUTANTS
Rodents are the unique species carrying duplicated AT1
receptor genes, Agtr1a and Agtr1b. After separately gener-
ating Agtr1a and Agtr1b null mutant mice by gene targeting,
we produced double mutant mice homozygous for both
Agtr1a and Agtr1b null mutation (Agtr12/2) by mating the
single gene mutants [7]. Agtr12/2 mice are characterized
by normal in utero survival rate but decreased ex utero
survival. Although the kidneys are macroscopically and
microscopically essentially indistinguishable from those of
wild-type mice at birth, they develop, by three weeks of age,
pronounced lesions in the renal cortex. In addition, the
papillae of homozygous mutant kidneys are reduced in size,
and the calices are expanded. Although these lesions are
progressive in nature, no discernible pelvic structure devel-
ops in null mutant mice, contrasting to the rapid develop-
ment of the pelvis seen shortly after birth in wild-type mice.
Thus, the AT1 receptor is essential for newborn mice to
develop pelvic structure, without which a typical hydrone-
phrotic pattern develops in the kidney. Using the ureter
dissected from E14.5 mouse embryos, we therefore studied
the role of the AT1 receptor for the ureteral smooth muscle
cell development [12]. E14.5 wild-type and Agtr1 null
mutant embryonic ureters were dissected and incubated.
Two ureters from each embryo were treated with either
vehicle alone or Ang II (1026 M) for 24 hours. The ureters
were stained for a actin to assess differentiation of the
mesenchyme into smooth muscle. Treatment with Ang II,
but not vehicle alone, leads to the appearance of distinctive
smooth muscle cell layers around the epithelium in the
wild-type ureter but not those from Agtr1 null mutants. We
conclude that Ang II affects the embryonic ureter and
promotes differentiation into the smooth muscle via AT1
and that inactivation of these receptors in null mutants may
lead to functional obstruction of the urinary tract system.
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